PARIS/ZURICH (Reuters) - France's competition authority is investigating drugmakers Roche and Novartis on suspicion they were involved in anti-competitive practices in respect of eye disease treatment, the companies said on Thursday. A statement on the authority's website said it had conducted "search and confiscation" operations on April 8 in relation to treatment for wet age-related macular degeneration (AMD), but it did not name the companies involved. "We can confirm the French antitrust authorities have started an investigation ... related to Avastin and Lucentis," said a Roche spokeswoman. "Our subsidiaries will fully co-operate." A Novartis spokeswoman said: "Novartis is aware of the ongoing investigation initiated by the French antitrust authority regarding anti-VEGF treatments for wet age-related macular degeneration and is cooperating with the authorities on the matter.
via Health News Headlines - Yahoo News http://ift.tt/1sEte5Y
No comments:
Post a Comment